Stockwinners Market Radar for January 12, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:03 EST Cathie Wood's ARK Investment bought 96K shares of Twist Bioscience today

20:02 EST Cathie Wood's ARK Investment bought 52.8K shares of Coinbase today

18:49 EST Adobe director sells $1.0M in common stock - In a regulatory filing, Adobe disclosed that its director John Warnock sold 3K shares of common stock on January 12th in a total transaction size of $1.0M.

18:23 EST Denbury CEO: We love where we are and where we're headed - In an interview on CNBC's Mad Money, Chris Kendall said Denbury is making great progress in the carbon capture industry. The door is "wide open" for this business, he added. "We have great cash flows and a clean balance sheet with virtually no debt. We're completely focused on building the value of the company," he noted.

18:08 EST NGM Biopharmaceuticals jumps 12% after Column Group buys $1.5M in shares - Shares of NGM Biopharmaceuticals are up 60c or up almost 12% to $5.65 per share in after hours trading after after holder Column Group buys $1.5M in shares. Beneficial owner of NGM Biopharmaceuticals Column Group, disclosed in a regulatory filing that it had purchased 309,070 shares of company stock at $4.79 per share between January 10 and January 11 for a total transaction amount of $1,479,364.

18:00 EST Semtech completes acquisition of Sierra Wireless - Semtech (SMTC) and Sierra Wireless (SWIR) "announced the completion of Semtech's acquisition of Sierra Wireless in an all-cash transaction representing a total enterprise value of approximately $1.2B. This transaction nearly doubles Semtech's annual revenue and adds approximately $100M of high-margin IoT Cloud services recurring revenues. Semtech expects the acquisition to be immediately accretive to non-GAAP EPS and to generate $40M of run rate operational synergies within 12-18 months post close."

17:32 EST Alphabet-owned Verily eliminates 15% of staff as it streamlines operations - Independent subsidiary of Alphabet, Life Sciences company, Verily said it was eliminating 15% of its workforce, in a blog post, on Thursday. Shared by Verily CEO Stephen Gillett, in part, with all Verily employees: "This is an important day for Verily, as we announce our refined strategy, prioritized portfolio and simplified operating model. This is work that has been in process for many months, and it's time to begin sharing our path forward with you...We are making changes that refine our strategy, prioritize our product portfolio and simplify our operating model. We will advance fewer initiatives with greater resources. In doing so, Verily will move from multiple lines of business to one centralized product organization with increasingly connected healthcare solutions. Going forward, we are going to do fewer things and leverage our strengths and capabilities in the process. This aligns with our purpose and puts us on a faster path to value creation for our customers and ultimate commercial success. Products will largely fall into research or care...to enable greater focus on our updated portfolio, we are discontinuing the development of Verily Value Suite and some early-stage products, including our work in remote patient monitoring for heart failure and microneedles for drug delivery...we cannot do everything and have had to make some difficult choices. Some Veeps will be redeployed to other teams; others will unfortunately be leaving us. These people have helped make Verily the company it is today, and I know how hard it is to see valued friends and colleagues depart. I have promised you all transparency in what we're doing, and this means we have eliminated approximately 15% of Verily roles due to discontinued programs, full control of Granular and Onduo, and redundancy in the new, centralized organization. We will continue in our search for Verily's next Chief Financial Officer, to be announced separately. We are hiring for a new Chief Scientific Officer, to be announced separately. Jordi Parramon, President of Verily's Devices business, will be leaving the company later this year, and will stay on as an advisor to help with the transition period." The Fly notes that on August 10, 2015, Sergey Brin announced that Verily would become an independent subsidiary of Alphabet. This restructuring process was completed on October 2, 2015. Reference Link

17:02 EST Zymeworks jumps 2% after holder EcoR1 Capital buys $8M in shares - Shares of Zymeworks are up almost 2% to $8.82 per share in after-hours trading on Tuesday, after share holder EcoR1 Capital disclosed it had purchased $7,874,081 in shares.

16:55 EST Zymeworks shareholder EcoR1 Capital buys $8M in company shares - Zymeworks shareholder EcoR1 Capital disclosed in a regulatory filing that it had purchased 1,026,300 shares of Zymeworks at $7.67 per share between January 10 and January 11 for a total transaction amount of $7,874,081.

16:34 EST Hanesbrands up about 3% at $8.15 after guiding Q4 revenue above consensus

16:32 EST Purple Innovation rejects unsolicited proposal from Coliseum Capital Management - Purple Innovation announced that the Special Committee of the Purple Board of Directors has rejected a $4.35 per share unsolicited, non-binding proposal from Coliseum Capital Management to acquire all of the outstanding stock of the company it does not already own. Coliseum, which beneficially owns approximately 44% of Purple's outstanding shares, sent the Proposal to the company on September 17, 2022. The Special Committee, which is comprised of independent directors, rejected the Proposal in November after conducting a comprehensive review of the company's long-range strategic plan and other opportunities in consultation with independent financial and legal advisors. In subsequent discussions with Coliseum, Coliseum was unwilling to offer more than $4.35 per share. At this time, the Special Committee continues to believe the Proposal is not in the best interests of the company and its shareholders.

16:29 EST EOG Resources sees Q4 net gain $233M on mark -to market of derivatives - For the fourth quarter of 2022, EOG anticipates a net gain of $233M on the mark-to-market of its financial commodity derivative contracts. During the fourth quarter of 2022, the net cash paid for settlements of financial commodity derivative contracts was $244M.

16:16 EST Royal Caribbean amends, extends revolving credit facilities - Royal Caribbean announced that it has successfully amended and extended the majority of its two unsecured revolving credit facilities. The amendment has extended the maturities of $2.3B of the $3B aggregate revolving capacity by one year to April 2025, with the remainder maturing in April 2024.

16:13 EST LendingClub chief capital officer, Valerie Kay, to depart - In a regulatory filing, Lending Club said, "On January 7, 2023, as part of the plan, the company decided to organizationally align responsibilities for the operation and utilization of our investor marketplace and bank balance sheet and, in doing so, eliminated the chief capital officer position. Accordingly, the final day of employment with the Company for the current chief capital officer, Valerie Kay, will be February 25, 2023."

16:08 EST Virgin Galactic up 6% after stating start of commercial service on track for Q2

16:05 EST Good Times Restaurants reports Q1 SSS up 3% - Good Times Restaurants "announced that same store sales for its first fiscal quarter ended December 27, 2022 increased 3.0% for its Good Times brand and increased 2.4% for its Bad Daddy's brand, and that average weekly sales during the first fiscal quarter were $26,797 and $49,180 for its Good Times and Bad Daddy's brands, respectively."

16:01 EST PerkinElmer CEO Prahlad Singh appointed to Amphenol board - Amphenol (APH) announced that Prahlad Singh, PhD has been appointed to Amphenol's board of directors. With his appointment, the size of the company's board has increased to 10 members. Dr. Singh is currently the President and CEO of PerkinElmer (PKI) and brings more than twenty-five years of global leadership experience to Amphenol's board. He was promoted to President and Chief Executive Officer of PerkinElmer effective December 30, 2019, and was appointed to its board of directors in 2019.

15:54 EST Vintage Wine Estates names Zach Long as Chief Operations Officer - Vintage Wine Estates announced two promotions that it said "further its efforts to advance its leadership team, develop talent from within and build greater bench strength." Zach Long, previously Senior Vice President of Winemaking and Production, will now serve as Chief Operations Officer and Jenna Duran, formerly Senior Director of Marketing, has been appointed Vice President of Marketing.

15:34 EST lululemon teams with Nedap to advance RFID technology across stores - Nedap has been selected by lululemon as their new provider for the deployment of Nedap iD Cloud, which will enhance its omni-guest experience across its 600+ stores globally by optimizing product availability. lululemon athletica inc. has partnered with Nedap as they continue to invest in a strong omni-guest experience across the globe. As stores are a significant point of connection and community for lululemon's guests, Nedap's iD Cloud platform is a crucial pillar to unlock real-time inventory data so that stores have the right product assortment available on their floors, creating a seamless experience across brick-and-mortar through digital engagement. "Our guests are at the center of everything that we do, and we are hyper-focused on creating strong guest connections through seamless store and online experiences," said Carl Barker, Vice President, Global Omni Programs at lululemon. "With Nedap's iD Cloud solution, we can leverage real-time, accurate data to enable our in-store educators to spend even more time engaging and connecting with our guests. Having a fully mobile cloud solution in our stores greatly contributes to this experience. Online, RFID continues to elevate our digital experience, offering accurate real-time store inventory visibility and powering key fulfillment experiences such as buy online, pickup in store ."

14:44 EST York Water announces settlement of Pennsylvania rate case - The York Water Company announced that the Pennsylvania Public Utility Commission, or PPUC, approved a joint settlement agreement at its January 12 public meeting, allowing an increase in base rates for water and wastewater customers of The York Water Company. "The approved rates provide for cost recovery for York Water and an expanded customer assistance program while maintaining affordability for customers. The new rates approved by the PPUC affect approximately 75,000 water and wastewater customers throughout York, Adams, and Franklin Counties, Pennsylvania. Even with the approved increases, York Water remains one of the lowest cost providers and most efficient water and wastewater utilities in the nation," the company said. JT Hand, President and CEO of York Water, stated, "Although water and wastewater remain the most affordable utilities, York Water is sensitive to economy-wide inflationary pressures and increased costs for our residential and business customers. We believe this is a fair and reasonable result that allows the company to recover approximately $176 million in recent investments in system improvements and infrastructure replacements and allows us to continue to meet the current and future needs of our customers."

14:01 EST Brown-Forman names Larry Combs chief information officer - Brown-Forman Corporation announced the appointments of Larry Combs to the newly created role of Chief Information Officer and Director of Supply Chain Integration and Strategy, and Melvin Keebler to the role of General Manager, Jack Daniel Distillery Supply Chain, effective immediately. "Supply chains across the globe have been under pressure for the last few years driven in part by a lack of modern technologies to address the stressors. This new role ensures Brown-Forman is well-positioned to leverage leading applications and technologies that will enhance our global supply chain and on-going operations," said Tim Nall, Senior Vice President, Chief Global Supply Chain and Technology Officer. Combs will be responsible for the strategic direction of Brown-Forman's application technologies, enterprise architecture, data and analytics strategy and framework, and portfolio management, as well as the continued development and execution of logistics, procurement, planning, and production strategies.

13:55 EST Okta says there will be some disruption from sales leadership changes - Says attrition peaked in first half of the last fiscal year. Says probably hired too many reps. Comments taken from Needham Growth Conference.

13:00 EST ZyVersa CEO says IPO window closed right now, may reopen this year

13:00 EST ZyVersa to begin treating patients with VAR 200 in 2023, CEO tells The Fly

12:00 EST AMTD Digital falls -11.4% - AMTD Digital is down -11.4%, or -$1.50 to $11.70.

12:00 EST Knot Offshore Partners falls -37.9% - Knot Offshore Partners is down -37.9%, or -$3.98 to $6.53.

12:00 EST ADC Therapeutics rises 20.1% - ADC Therapeutics is up 20.1%, or 86c to $5.13.

11:57 EST ViewRay announces publication on MRIdian MRI-Guidance in SBRT - ViewRay announced that findings from the phase III randomized controlled MIRAGE trial were published on January 12 in JAMA Oncology. The MIRAGE trial compared MRI-guided and CT-guided stereotactic body radiation therapy for localized prostate cancer and found MRI-guided radiation therapy - delivered with MRIdian - to be superior in substantially reducing acute genitourinary and gastrointestinal toxicity. MRI-guided radiation was also associated with significantly better patient-reported quality of life metrics. The MIRAGE trial was led by Amar Kishan, M.D. and Michael L. Steinberg, M.D. at the University of California, Los Angeles, The study was independently designed, conducted, and analyzed exclusively by UCLA. In this trial, the investigator team randomized 156 patients to receive either MRI-guided SBRT or CT-guided SBRT. Acute grade greater than or equal to2 GU toxicity rates were significantly lower with MRI guidance vs. CT guidance. Acute grade greater than or equal to2 GI toxicity rates were also significantly lower with MRI guidance. On multivariate analysis, which controls for differences in the use of a rectal spacer, prostate size, and baseline urinary symptoms, the MRI-guided arm was associated with a 60% reduction in odds of grade greater than or equal to2 GU toxicity. More notably, there were improvements in multiple patient-reported outcomes. Significantly more patients receiving CT-guided SBRT experienced large increases in urinary symptoms, as measured by a greater than15 points increase in International Prostate Symptom Score. Similarly, a significantly greater percentage of patients experienced a clinically notable decrease in bowel-related quality of life with CT-guided, as measured by the Expanded Prostate Cancer Index Composite-26 survey. Finally, though it is too early to conclude, as more than 2/3rds of men on the trial received hormonal therapy, exploratory analysis in men who did not receive hormonal therapy showed that patient-reported sexual-function scores decreased more in men receiving CT-guided SBRT.

11:17 EST PayPal's Xoom service expands debit card deposit feature - Xoom, PayPal's international money transfer service, announced that it has launched a new cross-border money transfer product, Debit Card Deposit, enabling Xoom customers in the U.S. to send money directly to their friends & family's eligible Visa debit cards in 25 countries. Launched in collaboration with Visa, the new feature will offer remittance receivers easy, secure and real-time2 access to funds, which are sent directly to a recipient's eligible Visa debit card. Xoom's Debit Card Deposit feature first launched in 2020 for U.S. domestic money transfers, and the new cross-border expansion increases the ability for international recipients to easily and quickly access funds sent from friends and family in the U.S. With the Xoom Debit Card Deposit functionality, recipients have access to use those funds typically within minutes however they need, such as paying bills or buying groceries, through their eligible debit card. Xoom's Debit Card Deposit feature is now available in the following 25 markets: Bosnia and Herzegovina, Bulgaria, Costa Rica, Croatia, Czech Republic, Great Britain, Greece, Guatemala, Hungary, Indonesia, Israel, Italy, Jamaica, Lithuania, Malaysia, Pakistan, Philippines, Romania, Singapore, Slovakia, Spain, Sri Lanka, Thailand, Ukraine, and Vietnam. Debit Card Deposit will continue to roll-out across additional markets in 2023. Reference Link

11:13 EST PureTech Health PLC (ADR) trading resumes

11:01 EST Panbela Therapeutics announces 1-for-40 reverse stock split - Panbela Therapeutics announced that it will implement the previously announced and stockholder approved 1-for-40 reverse split of its common stock. The reverse stock split will be effective as of the morning of January 13, 2023, and the company's common stock will trade on a post-split basis at the beginning of trading on the same date under the existing trading symbol "PBLA." The CUSIP number for the common stock following the reverse stock split will be 69833W206.

10:29 EST Ohio AG continues to apply pressure to Dollar General stores - Ohio Attorney General Dave Yost returned to court to ask a Butler County Common Pleas judge to "immediately force" Dollar General to stop "advertising one price on its store shelves and charging another price - typically higher - at its registers," adding that "deceptive pricing" continues at the retailer's stores. In his request for a temporary restraining order against the discount retailer, Yost cited ongoing violations of the Ohio Consumer Sales Practices Act. He also requested a hearing regarding a preliminary injunction that would require Dollar General to abide by Ohio consumer laws as this case progresses. According to the AG, multiple county auditors, as part of their regular duties, have inspected Dollar General stores and found that many of the product prices displayed did not match the prices charged. Yost sued the company on Nov. 1, 2022. In the months since the lawsuit was filed, the Attorney General's Office says it has received 116 complaints regarding Dollar General's shelf-pricing issues. Reference Link

10:04 EST Rent The Runway launches Amazon Fashion storefront - Rent the Runway (RENT) is launching a new Amazon Fashion (AMZN) storefront to sell a selection of its Pre-Loved and exclusive Design Collective apparel. The collection of Pre-Loved merchandise includes hundreds of styles from over 35 brands, spanning casual weekend wear, workwear, date night apparel and seasonal essentials like sweaters, tops, coats and denim. This new online storefront will offer Amazon Fashion customers another affordable way to refresh their wardrobes. In addition, the company will introduce an exclusive selection of merchandise from its Design Collective, only available new through Amazon Fashion and renttherunway.com. Through Design Collective, Rent the Runway gives top design talent an opportunity to create limited-edition collections informed by Rent the Runway's proprietary data and insights from its community of customers. As a result, these pieces are amongst the company's most popular. Through this launch with Amazon Fashion, Rent the Runway deepens its commitment to being a customer discovery platform for designer brands by providing an even wider stage for them to introduce their products to new audiences.

10:00 EST Unity falls -8.2% - Unity is down -8.2%, or -$2.68 to $29.88.

10:00 EST Knot Offshore Partners falls -43.3% - Knot Offshore Partners is down -43.3%, or -$4.54 to $5.96.

10:00 EST Mizuho Financial Group rises 6.0% - Mizuho Financial Group is up 6.0%, or 17c to $3.08.

09:47 EST Expro falls -7.3% - Expro is down -7.3%, or -$1.34 to $17.11.

09:47 EST Knot Offshore Partners falls -40.5% - Knot Offshore Partners is down -40.5%, or -$4.25 to $6.25.

09:47 EST AMC Entertainment rises 8.3% - AMC Entertainment is up 8.3%, or 41c to $5.33.

09:30 EST Capricor Therapeutics announces publication engineered exosome platform - Capricor Therapeutics announced the publication of a preclinical study highlighting new advances for its engineered exosome program. The data was published online in bioRxiv and explored the therapeutic potential of Capricor's proprietary StealthX exosome platform, which generated two vaccine candidates, that independently, and in combination induced a strong immune response against two SARS-CoV-2 proteins, spike and nucleocapsid. Results showed that this multivalent, protein-based vaccine candidate has the potential to achieve potent, longer lasting immunization, broaden reactivity and improve T-cell response with only nanograms of protein without any adjuvant. The data from this study suggests that StealthX could deliver a more potent vaccine with broader immunity than is currently available, by combining the advantages of both mRNA and recombinant protein vaccines into a potentially superior, rapidly generated, low-dose vaccine. The current study used engineered exosomes to express either SARS-CoV-2 spike or nucleocapsid protein on the exosome surface rapidly, a timeframe similar to mRNA vaccines. When administered as a single product, both STX-S and STX-N induced strong immunization with the production of a potent humoral and cellular immune response simultaneously. These effects were obtained with administration of only nanograms of protein without the use of any adjuvant or lipid nanoparticles which further supports the potential safety profile of this product candidate. The study also investigated the combination of STX-S and STX-N, namely STX-S+N, in two independent animal models. Administration of this multivalent, low dose protein-based vaccine resulted in increased, persistent antibody production, potent neutralizing antibodies with cross-reactivity to other variants of concern, and strong T-cell response. The results show efficacy of this multivalent protein-based vaccine for SARS-CoV-2 and suggests that other vaccines or therapeutics could be rapidly developed using the same StealthX platform.

09:28 EST BigBear.ai rockets 351% in pre-market on Air Force contract announcement - Shares of BigBear.ai are up 351% or $2.97 to $3.82 in pre-market after the company announced that it has secured a 10-year multiple award $900M IDIQ contract with Air Force.

09:26 EST Sabina Gold & Silver finalizes lump sum contract for plant construction - Sabina Gold & Silver announces it has finalized the lump sum contract with a northern constructor to build the process plant and ancillary buildings at its Goose Mine on its 100% owned Back River Gold District in Nunavut, Canada. The Goose Mine is the Company's first mine on the 80 km long Back River Gold District, a multi-generational mining district with a demonstrated high-grade world class gold endowment. CGT has provided Sabina with a fixed priced contract of CAD $139 Million for materials and labour to construct the process plant including: crushing circuit, grinding circuit, CIL circuit, pre-leach and tails thickener with tails pumping, gold room, E-houses, control room, O2 plant, fresh water, truck shop, and fire water systems. Additional scope has been added to the original bid proposal which includes the power plant and the Port fuel farm. The contract includes an agreed rise and fall mechanism and other mechanisms to adjust for changes in bid quantities due to design growth and scope changes. These components make up approximately 85% of the direct works on site.

09:25 EST Crown Electrokinetics says Amerigen 7 acquisition could add revenue of $30M - Crown Electrokinetics has released a letter to its shareholders. The company said, " Approximately one week ago, Crown announced that it had entered into an asset purchase agreement with Amerigen 7, an emerging leader in the fields of distributed antenna systems and construction of fiber optic networks. Crown did this for two primary reasons; to market and sell distributed antennas systems to our targeted customer base and to generate revenue and cash flow from the construction of the fiber optic network for Charter Communications. The business combination is already underway with Amerigen 7 rebranded and renamed as Crown Fiber Optics. We believe the acquisition could add revenue of approximately $30 million and EBITDA of $10 million in 2023. Our customers have expressed an interest in solving two problems: the inefficiency of their windows and the inability of 5G signals to penetrate their buildings. Crown's Smart Window Inserts will help building owners solve many of the problems with their external windows and Crown's Distributed Antenna Systems will allow for a stronger cellular signal within our customer's buildings. We are already cross selling and marketing both our inserts as well as our newly offered distributed antenna systems. The global distributed antenna system market was valued at $8.4 billion in 2021 and is expected to grow to $15.7 billion in 2030, driven by increased mobile data traffic and connected devices, as well as a growing preference for extended and undisrupted internet connectivity. Additionally, there is a significant public investment planned for communications infrastructure including the Bipartisan Infrastructure Law which provides $65 billion in funding to expand high-speed Internet access across the US. This type of infrastructure investment represents a significant opportunity for Crown Fiber Optics which is a prime contractor for Charter Communications in Wisconsin, Michigan, Indiana, Ohio and Pennsylvania. Crown Fiber Optics has a signed purchase order for a $67 million project in Ohio, constructing the fiber optic network for Charter Communications...Lastly, we continue to engage in discussions with debt providers to tailor a funding solution that not only encompasses our electrokinetic film manufacturing, but also our fiber optic construction business. The addition of Amerigen 7 assets has bolstered support for those ongoing discussions. We expect to have further operational and funding updates in the near future and believe 2023 should prove to be a truly transformative year for Crown. We appreciate your support and are excited to take this new path with all of you."

09:23 EST Freddie Mac issues $65B in 2022 securities - Freddie Mac issued $65.1 billion of securities through its Multifamily risk transfer platform in 2022. A leading issuer of multifamily securities, the company settled $46.5 billion in K-Deals and forwardly placed $14.7 billion through its When-Issued K-Deal(R). Freddie Mac Multifamily also increased issuance through its Multi PCs to $11.6 billion, up from $7 billion in 2021, leveraging MSCR Notes and MCIP reinsurance tools for back-end risk transfer. "In the face of turbulent capital markets, Freddie Mac continued to provide a steady issuance of Multifamily securities throughout 2022," said Robert Koontz, senior vice president of Multifamily Capital Markets for Freddie Mac. "With the support of our growing investor base, we also continued to diversify, optimize and innovate our risk transfer technologies. These efforts helped Freddie Mac reach new heights in our support of affordable and workforce housing throughout the county."

09:22 EST Playboy Spirits closes over $13M in funding - Playboy Spirits, a joint venture formed by PLBY Group and XL Ventures II, announced the initial closing of more than $13 million in funding from a private placement of senior secured convertible notes by the joint venture's wholly-owned operating subsidiary, and may receive additional funds in a subsequent closing. Playboy Spirits is owned 40% by a wholly owned subsidiary of PLBY Group and 60% by XLV. Conversion of the Notes could result in the dilution of Playboy Spirits' ownership of the Operating Subsidiary by up to 50% but would not reduce Playboy Spirits' managerial control of the business. The capital raised will fund the operations of Playboy Spirits and the Operating Subsidiary's business, including the continued acquisition of rare, aged spirits to be released under the Rare Hare brand with Playboy co-branding. Playboy Spirits holds a trademark license to use Playboy branding and artwork with royalties payable to Playboy from the sales of all Playboy Spirits products. Playboy Spirits' and the Operating Subsidiary's operations are primarily run by SIP pursuant to a professional services agreement. In 2023, Playboy Spirits expects to release limited-edition spirits in the U.S. and Asia, and plans to enter the ready-to-drink canned beverage category.

09:21 EST Check Point announces Tzipi Ozer-Armon joins board - Check Point Software Technologies announced Ms. Tzipi Ozer-Armon has joined the company's Board of Directors following her appointment at the 2022 Annual General Meeting.Ms. Ozer-Armon serves as the Chief Executive Officer of Lumenis. Before joining Lumenis, she headed the Japanese market activities of Teva Pharmaceutical Industries and served as Senior Vice President of Sales and Marketing at SanDisk. Previously, Ms. Ozer-Armon also served as VP & General Manager at MSystems. In addition to Check Point Ms. Ozer-Armon is a director at ICL, Strauss Group Ltd. And SimilarWeb. Ms. Ozer-Armon holds a BA degree, magna cum laude, in Economics, and an MBA degree in Finance and Marketing from Tel-Aviv University, and she is an AMP graduate of the Harvard Business School.

09:18 EST LPL Financial: Fenton Wangler joins broker-dealer, RIA, custodial platforms - LPL Financial LLC announced that financial advisors Eric Fenton and Rodney Wangler have joined LPL Financial's broker-dealer, RIA and custodial platforms, aligned with JFC Advisor Network. They reported having served approximately $300 million in advisory, brokerage and retirement plan assets, and join LPL from Securities America, part of the Advisor Group network. Based in Vancouver, Wash., the advisors founded Fenton Wangler Financial in 2001 with a mission to provide independent financial services focused heavily on personalized financial planning and risk management.

09:16 EST CareCloud Charts receives ONC certification - CareCloud announced its electronic health record platform CareCloud Charts received Office of the National Coordinator for Health Information Technology certification ahead of last year's Dec. 31 deadline. In accordance with the requirements of the 21st Century Cures Act Final Rule, CareCloud Charts' ONC certification means the EHR platform has been approved to provide the necessary functionality that supports seamless and secure access, exchange and use of electronic health information. CareCloud Charts was tested and certified in December 2022 by Drummond Group LLC, an authorized certification body and the leading certification body for ONC's Health IT Certification Program. CareCloud's other EHR solutions, talkEHR and VertexDR, were certified under the same standards at the beginning of November 2022. All three EHR platforms now include standardized application programming interfaces for patient and population services, encryption authentication, and interoperability through certification. To maintain certification, CareCloud's EHR developers must resubmit attestations every six months.

09:13 EST Ethos Real Estate closes $76M purchase of Residences at Woodlake - Ethos Real Estate announced the company has closed on the $76 million purchase of the Residences at Woodlake, a 276-unit multifamily property in the Crenshaw District of Los Angeles. Under the deal, Ethos will be converting the formerly market rate property into deed restricted affordable housing through a unique public private partnership that leverages a California statutory property tax exemption. Under the deed restriction, half of the units will be restricted to families earning up to 80% of the Average Median Income for Los Angeles, and 10 percent will be restricted to families earning up to 60% of AMI, for 55 years. The property was the second purchase for Ethos' joint venture with GCM Grosvenor, investing on behalf of its clients.

09:12 EST Aware says federal agencies used biometric authentication solutions in 2022 - Several well-known U.S. federal government agencies have enlisted or expanded their use of Aware, biometric authentication solutions in 2022, according to the company. As of today, Aware's solutions are being used across all three branches of the U.S. federal government, as well as 12 out of 15 executive departments within the executive branch. Such broad industry application attests to Aware's trustworthiness, and proven expertise in meeting this sector's needs for robust technology within highly secure biometric-based authentication systems.

09:10 EST Iveda Solutions announces $1.5M Utilis Smart Pole deployment - Iveda announced the launch of a $1.5 million project for Utilis Smart Pole technology in Kaohsiung, Taiwan, equipping the country's largest harbor city with critical IoT infrastructure for smart city deployments. Utilus brings Iveda technology--including video surveillance, AI-based video analytics, IvedaSPS, and IvedaPinpoint--together in a centralized platform, which is integrated into existing infrastructure for true smart city implementations. Utilis' smart, multi-purpose poles will help Kaohsiung solve a myriad of urban challenges, from improving parking and traffic management and charging electric vehicles, to detecting and notifying officials about street flooding, all through real-time data and alerts.

09:08 EST Velodyne announces Glass, Lewis, & Co recommends stockholders vote 'FOR' merger - Velodyne Lidar (VLDR) announced that independent proxy advisory firm Glass, Lewis & Co. has recommended that shareholders vote "FOR" the proposed merger with Ouster (OUST) at the Company's upcoming Special Meeting of Stockholders, scheduled for January 26, 2023. "The combination of Ouster and Velodyne is expected to unlock enormous synergies, creating a company with the scale and resources to deliver stronger solutions for customers and society, while accelerating time to profitability and enhancing value for shareholders," said Dr. Ted Tewksbury, CEO and member of Velodyne's Board of Directors. Dr. Tewksbury will serve as Executive Chairman of the combined company upon the successful completion of the proposed merger. "The merger is a transformational transaction that the Board believes best positions the company to generate long-term value for all stockholders," continued Dr. Tewksbury. "Velodyne is pleased that Glass Lewis shares the belief that the proposed merger with Ouster is in the best interests of Velodyne's stockholders and supports the Board's unanimous recommendation that shareholders vote "FOR" the transaction."

09:07 EST SentinelOne selected by JCDC to strengthen U.S. cybersecurity - SentinelOne announced its membership in the Joint Cyber Defense Collaborative, JCDC, to further support the U.S. government's strategy to secure the cyber ecosystem and critical infrastructure. As part of its membership, JCDC will leverage the expertise of SentinelLabs. As part of the collaboration, SentinelOne will provide JCDC with insights and support in strategic planning and advisement. This partnership will give JCDC unparalleled visibility into emerging threats and help them stay ahead of potential attacks.

09:05 EST Processa Pharmaceuticals to focus on oncology pipeline - In a regulatory filing earlier this week, Processa Pharmaceuticals announces that it plans to focus on next generation of chemotherapy drugs with high probability of approval, with PCS12852 and PCS499 seen as candidates to be partnered out. Reference Link

09:05 EST Velo3D appoints Stamp as Director of Solutions Engineering - Velo3D announced it has appointed Dr. Robin Stamp as Director of Solutions Engineering to help grow the adoption of Velo3D's metal additive manufacturing technology with new customers and in new industries. In his role, Dr. Stamp will oversee the development of new standards with regulatory agencies, qualification of new metal alloys for use in the Sapphire family of printers, and the collaboration with partners and agencies. Dr. Stamp was previously a principal engineer at SpaceX, where he worked on developing technology for space applications.

09:05 EST Albertsons and Afresh Technologies roll out AI-powered retail platform - Albertsons and Afresh Technologies, a fresh food technology company, completed an enterprise rollout of the Afresh predictive ordering and inventory management platform across nearly all of Albertsons Cos.' banner stores across the country. The system was fully deployed in more than 2,000 stores in seven months. Afresh aims to enable Albertsons Cos. banner store teams to reduce food waste and achieve superior freshness in their stores. The solution powers Albertsons Cos.' forecasting, inventory and store operations. Afresh claims that grocers utilizing Afresh typically see an increase in sales by an average of 3% across their chain while reducing food waste by 25% and significantly improving inventory turns.

09:03 EST STMicroelectronics introduces STM32C0 series microcontrollers - STMicroelectronics is again broadening access to its STM32 microcontroller (MCU) family by introducing the most affordable series yet: the STM32C0.In assuring availability, ST targets the new STM32C0 series to equipment like home appliances, industrial pumps, fans, smoke detectors, typically served by simpler 8-bit and 16-bit MCUs. The modern, 32-bit design of the STM32C0 permits improvements such as faster response, extra functions, and network connection at similar overall cost and power consumption. At the same time, its entry-level simplicity and free and extensive support ecosystem with resources including tools, software packs, and the chance to connect with various developer communities ease entry to the 32-bit world for new users.

09:02 EST Robinhood opens Robinhood Retirement to all eligible customers - Robinhood Markets announced that Robinhood Retirement is now available to all eligible customers. Robinhood Retirement, which launched via waitlist in December, is the first and only IRA to offer a 1% match for every eligible dollar contributed. Since it was first announced, Robinhood has granted access to more than 1 million people on the retirement waitlist.

09:01 EST Remark Holdings regains Nasdaq compliance - Remark Holdings announced that it received a letter from The Nasdaq Stock Market LLC confirming that it has regained compliance with the $1.00 minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2). Accordingly, the Nasdaq Hearings Panel has determined that the company's common stock will continue to be listed on the Nasdaq Stock Market and as a result, considers this matter now closed.

08:56 EST Adeia renews multi-year IP license agreement with Fetch TV - Adeia announced that Fetch TV, a leading Australian content aggregation platform has renewed a multi-year agreement to license Adeia's media intellectual property portfolio. "As consumer demand for content aggregation services in Australia grows, market leaders like Fetch are integrating the latest innovations to ensure that viewers have seamless access to a growing selection of high-quality entertainment experiences. This patent license extension with Fetch further confirms the value and longevity of Adeia's intellectual property portfolios, including in Australia's vibrant home entertainment market," said Dr. Mark Kokes, Adeia's chief licensing officer and general manager of media.

08:51 EST iSun wins three new solar contracts valued at $9.7M - iSun announced that it was awarded three contracts with a total value of $9.7M to implement solar energy solutions in communities in northern New England. The new projects result from a new partnership that iSun has formed with an integrated nationwide solar developer. HIGHLIGHTS: New awards of 9.0 MW in total will add to iSun's already completed portfolio of projects in northern New England; Three new contracts valued at $9.7 million together underscore iSun's ability to help construct significant commercial projects that advance the implementation of solar energy; New partnership with a nationwide integrated solar developer demonstrates iSun's experience and responsiveness; and Projects are underway and expected to be completed this year. "The three project awards from our new partner represent important wins for our team as we continue to demonstrate our ability to expand our customer base across New England," said Jeffrey Peck, Chairman and Chief Executive Officer of iSun. "We are working diligently to address the continued strong customer demand for solar energy in our markets, and I'm very pleased with the success of our team in cultivating long-term customer relationships for iSun. The transition to clean energy remains the most important initiative of our generation and we are proud to assist more customers throughout our markets in achieving alternative energy solutions."

08:49 EST HP Enterprise acquires Pachyderm to expand AI-at-scale capabilities - Hewlett Packard Enterprise announced an expansion to its AI-at-scale offerings with the acquisition of Pachyderm, a startup that delivers software, based on open-source technology, to automate reproducible machine learning pipelines that target large-scale AI applications. "As AI projects become larger and increasingly involve complex data sets, data scientists will need reproducible AI solutions to efficiently maximize their machine learning initiatives, optimize their infrastructure cost, and ensure data is reliable and safe no matter where they are in their AI journey," said Justin Hotard, executive vice president and general manager, HPC and AI, at HPE. "Pachyderm's unique reproducible AI software augments HPE's existing AI-at-scale offerings to automate and accelerate AI and unlock greater opportunities in image, video, and text analysis, generative AI, and other emerging large-language-model needs to realize transformative outcomes."

08:48 EST NLS Pharmaceutics to host R&D update webcast - NLS Pharmaceutics announced plans to showcase its global strategic R&D progress and platform, as well as its product candidate and pipeline goals for 2023, with a focus on rare and complex CNS disorders with unmet medical needs. NLS will webcast its upcoming virtual R&D Day event on the Investors section of the Company's website, www.nlspharma.com, on January 31, 2023, at 10:00 am EST.

08:47 EST UserTesting completes acquisition of Thoma Bravo, Sunstone - UserTesting announced the completion of its acquisition by Thoma Bravo and Sunstone Partners, in an all-cash transaction valued at approximately $1.3B. The agreement to be acquired was previously announced on October 27, 2022 and approved by UserTesting stockholders at the Special Meeting of Stockholders held on January 10, 2023. With the completion of the transaction, UserTesting stockholders are entitled to receive $7.50 per share in cash for each share of UserTesting common stock they owned. UserTesting's common stock has ceased trading and will be delisted from the New York Stock Exchange.

08:46 EST HeartCore CMS introduced as platform by Subaru Group - HeartCore Enterprises (HTCR) announced that HeartCore CMS, the Contents Management system provided by HeartCore, has been introduced by Subaru Group (FUJHY) to its centralized management platform for approximately 100 Subaru websites. An advertisement introducing the background of the integration has been released, which can be found here.The advertisement explains that Subaru has developed a common Web infrastructure using HeartCore CMS as a measure to strengthen their internal Web governance in Japan. In the process, they consolidated approximately 100 websites within Subaru into this single environment. As a result, HeartCore CMS will be used to enhance the governance and security of the website, realizing Subaru's "Safety and Security" on the website infrastructure.HeartCore will continue to introduce HeartCore CMS as the foundation for website operation and content management for companies and organizations.

08:42 EST Safe-T announces corporate rebranding to Alarum Technologies - Safe-T Group announced a corporate rebranding in response to accelerated company growth. At the heart of this rebranding is a change of the Company's name to Alarum Technologies Ltd. to embody its corporate vision and core values. The new name, Alarum, is derived from the Latin word for "warning" and is rooted in the Company's focus and commitment to provide advanced privacy and cybersecurity solutions. Over the past 18 months, the Company anchored its position as the market leader of cybersecurity and privacy solutions. It has experienced significant growth, which reflects the increasing recognition by private and enterprise customers that choose the value-added benefits of the Company's various solutions. The rebranding as Alarum better reflects the Company's current business as a provider of cybersecurity and privacy solutions for consumers and enterprises, and better expresses the Company's evolving identity and diversified growth ambitions. CEO Shachar Daniel, commented: "At Alarum, our mission is to enable a secure network environment and protect organizations and individuals from privacy breaches and cyber-attacks. Our commitment to our customers, partners and shareholders remains our highest priority and we are excited to embark on this new chapter under the Alarum brand." The rebranding includes a new name and an update to the Company's corporate logo and website. Alarum's Nasdaq and TASE trading symbols will change to ALAR. The Company will continue to trade under its current name until regulatory processes are finalized. The Company expects the transition to be completed and take effect on January 25, 2023. There will be no change to the Company's CUSIP number.

08:41 EST ChromaDex appointed Bohr to its SAB - ChromaDex announced it has appointed Dr. Vilhelm Bohr, M.D., Ph.D., D.Sc. to its Scientific Advisory Board, SAB. For the past 30 years, Dr. Bohr served as Chief of the Laboratory of Molecular Genetics at the National Institute on Aging, which is part of the National Institute of Health.

08:38 EST Milestone Scientific in distribution pact with European dental distributor - Milestone Scientific announced it has entered into a distribution agreement with Sweden & Martina, a leading European dental distributor and manufacturer. Under the agreement, Sweden & Martina has been awarded the exclusive rights to market Milestone's STA Single Tooth Anesthesia System in the new markets of Spain, Portugal and France. In addition, Sweden & Martina will replace the Company's current distributor in Italy and become its exclusive STA distributor in this market. Head of Global Business Development, Mr. Leonardo Lago of Sweden & Martina, stated, "We are excited to start our collaboration with Milestone Scientific, and we strongly believe in the STA technology as an evolution of the anesthetic method in dentistry. We are sure it will be a successful partnership for both companies."

08:37 EST Thermo Fisher joins Momentum Labs as a founding sponsor of biotech hub - Thermo Fisher Scientific announced it has become a founding sponsor of Momentum Labs in Alachua, Fla. Momentum Labs will serve as a collaborative laboratory and office space for growing biotech businesses in the greater Gainesville region. The venture is spearheaded by Concept Companies, a national real estate development firm headquartered in Gainesville. "From a regional and state perspective, Momentum Labs provides critical infrastructure and business development resources to support the growth of life sciences in Florida, giving the ecosystem the opportunity to retain companies rather than losing them to other communities," said Abhinav Akhoury, vice president, corporate accounts, Thermo Fisher Scientific. "Through our sponsorship, Momentum Labs has the ability to provide the latest innovative technologies to high-growth life science companies that are developing tomorrow's life-changing medicines."

08:36 EST VolitionRx: Nu.Q Vet Cancer Test available through Idexx Laboratories network - VolitionRx (VNRX) announces the availability of its Nu.Q Vet Cancer Test through the IDEXX Laboratories (IDXX) reference laboratory network in the U.S.

08:35 EST Verizon surpasses 3.0 gigawatts of projected renewable energy capacity - Verizon signed four new long-term renewable energy purchase agreements for an aggregate of up to 410 megawatts of renewable energy capacity. With these new agreements, Verizon has surpassed 3.0 gigawatts of total projected renewable energy capacity, as it continues to be a leading buyer of U.S. renewable energy. These agreements also position the company to meet its goal to source or generate renewable energy equivalent to 50 percent of its total annual electricity consumption by 2025. Since 2019, Verizon has signed 24 REPAs for more than 3.0 GW of projected renewable energy capacity, which is roughly equivalent to 8.4 million megawatt hours of annual electricity production, enough to power more than 707,000 homes for a year. These agreements also support Citizen Verizon, the company's responsible business plan for economic, environmental and social advancement.

08:34 EST Edible Garden achieves above-industry order fulfillment rates - Edible Garden announced that it has achieved above-industry order fulfillment rates, which led in part to a successful 2022 holiday season. Jim Kras, CEO of Edible Garden, commented, "We are proud to report that during the recent 2022 holiday season, the Company's order fulfillment rate across all of our retailers and distribution partners contributed to a successful holiday season. Our overall fill rate exceeded industry averages, and in particular, we achieved a fill rate in excess of 100% at one of the nation's largest operators of supercenters, further strengthening our existing relationship with this retailer. Achieving this level of performance, despite the unprecedented supply chain challenges facing the industry, demonstrates the high levels of service and execution that Edible Garden is able to provide to its customers. By continuing to exceed our partners' expectations, not only during the holiday season, but throughout the entire year, we believe that our partners have gained confidence in Edible Garden as a trusted, dependable supplier for sustainably grown produce."

08:33 EST Cognizant appoints Ravi Kumar S as CEO - Cognizant has named Ravi Kumar S as CEO and a member of the Board, effective immediately. Kumar succeeds Brian Humphries in both roles. To facilitate a smooth transition, Humphries will remain with the company as a special advisor until March 15, 2023. Kumar joins Cognizant after a 20-year career at Infosys, where he held various leadership roles, most recently serving as President from January 2016 through October 2022. Stephen Rohleder, a member of Cognizant's Board since March 2022, has been elected Chair of the Board. Former Chair Michael Patsalos-Fox will remain on the Board as an independent director. Rohleder joined the Board in March 2022 as part of the Board's ongoing Board refreshment process. In connection with the CEO transition, Cognizant has also named Surya Gummadi President, Cognizant Americas. Gummadi had held the role on an interim basis since July 2022 and previously served as SVP of Cognizant's Health Sciences business segment.

08:31 EST T. Rowe Price reports preliminary AUM $1.28T at December 31, 2022 - T. Rowe Price reported preliminary month-end assets under management of $1.28T as of December 31, 2022. Preliminary net outflows for the fourth quarter of 2022 were $17.1B, bringing preliminary year-to-date net outflows to $61.7B.

08:27 EST Cuentas appoints Lexi Terrero to board of directors - Cuentas announced the appointment of Lexi Terrero as a new independent director to its Board. Terrero is a Managing Partner of The Flo Lab, a Full-Service Marketing Agency with offices in New York, Miami & Dallas.

08:25 EST Zentek appoints Mitch Swergold as director of investor relations - Zentek welcomes Mitch Swergold as its Director of Investor Relations. After practicing law and serving as a research analyst at two investment banks, Swergold was a Senior Analyst and Portfolio Manager at various hedge funds, focusing on technology and macroeconomic investing. Swergold's responsibilities include assisting management in presenting updated business information to investors, communicating with investors and related functions. Concurrent with the appointment, and in accordance with the Company's long-term incentive plan, the Company has granted 50,000 incentive stock options to Swergold, which are exercisable, subjecting to vesting provisions, over a period of three years at an exercise price of $1.93. Additionally, Swergold is currently the holder of 36,700 common shares in the capital of the Company.

08:23 EST Ventyx Biosciences appoints Allison Hulme, Ph.D. to board - Ventyx Biosciences announced the appointment of Allison J. Hulme, Ph.D. and Onaiza Cadoret-Manier to its board of directors. Dr. Hulme and Ms. Cadoret-Manier are both successful executives who each bring a wealth of knowledge from more than 30 years of experience in biotech and pharmaceutical drug development and commercializatio. Dr. Allison Hulme currently serves as Chief Executive Officer, President and a board member of Aeovian Pharmaceuticals. Prior to this, she served as Chief Operating Officer, Head of Research and Development and a board member at Sophiris Bio. Prior to joining Sophiris, Dr. Hulme served as the Executive Vice President and Head of Global Development at Elan Corporation. Before Elan, Dr. Hulme held several positions in clinical research at Glaxo Wellcome Pharmaceuticals and was a lecturer in biological sciences at University of Bedfordshire. Dr. Hulme holds a Ph.D. in Biotechnology from Cranfield Institute of Technology and a Bachelor of Science in Combined Sciences from Luton University in 1985. Onaiza Cadoret-Manier currently serves as Executive Vice President, Chief Global Product Strategy and Operations officer at Ionis Pharmaceuticals. Prior to Ionis, she served as the Chief Commercial Officer for Grail Biosciences. Prior to Grail, she served as Vice President of the immunology franchise at Genentech. Ms. Cadoret-Manier also has held multiple senior management positions overseeing corporate strategy, alliances and marketing and sales for Genentech, Pfizer and Amylin Pharmaceuticals. Ms. Cadoret-Manier currently serves on the board of Ardelyx. Onaiza has an MBA from the University of Chicago and a bachelor's degree in economics and accounting from Queens College of City University of New York.

08:20 EST Labrador Gold announces results from drilling at Appleton Fault Zone - Labrador Gold announced the latest results from recent drilling targeting the highly prospective Appleton Fault Zone over a 12km strike length. The drilling is part of the Company's ongoing 100,000 metre diamond drilling program at its 100% owned Kingsway Project. Highlights of the drilling include an intersection of 20.88 g/t Au over 5 metres that included 124.21g/t Au over 0.81 metres and 7.41 g/t Au over 1.0 metres in Hole K-22-206, and 6.04 g/t Au over 1.20 metres in Hole K-22-208. Both holes were drilled at the north end of Big Vein. "We continue to follow up on the success of last year's drilling at Big Vein with another high-grade intersection at the north end of the zone. Big Vein has now been drilled over a strike length of approximately 520 metres along the west side of the Appleton Fault Zone and remains open to the northeast and to the southwest," said Roger Moss, President and CEO. "Drilling is ongoing at both ends of the zone to extend the strike length of the mineralization."

08:18 EST PetVivo announces plan for new manufacturing facility - PetVivo Holdings announced it has entered into a lease agreement for approximately 14,000 sq. ft. of production and warehouse space located in Edina, Minnesota. This new facility will include multiple clean rooms for large-scale production of Spryng with OsteoCushion Technology, as well as other medical devices and therapeutics in the PetVivo product pipeline. The Company plans to move all of its production to this facility beginning in August 2023. "Moving ahead with this manufacturing facility represents a significant commitment in bringing our life changing product Spryng to horses and small animals suffering from lameness throughout the world," said John Lai, Chief Executive Officer for PetVivo Holdings, Inc. ""Expanding our manufacturing footprint provides us the with the production capacity to meet our growth objectives for Spryng and other medical devices and therapeutics of tomorrow."

08:16 EST Inari:1st patient enrolled in 'clinical outcomes' study of ClotTriever for DVT - Inari Medical announced that the first patient has been enrolled in DEFIANCE, a prospective randomized controlled trial comparing the clinical outcomes of patients with iliofemoral deep vein thrombosis treated with the ClotTriever System versus anticoagulation only. The trial is led by Principal Investigators: Dr. Xhorlina Marko, Interventional Radiologist at Beaumont Health; Dr. Steven Abramowitz, Chair of Vascular Surgery at MedStar Health; and Professor Stephen Black, MD, consultant vascular surgeon, Guy's and St. Thomas' Hospital, London. The first DEFIANCE patient was enrolled by Dr. Abdullah Shaikh, Interventional Radiologist at Allegheny Health Network, Pittsburgh, PA. DEFIANCE will enroll 300 DVT patients at up to 60 centers worldwide. DEFIANCE is Inari's second RCT, enrolling in parallel to the PEERLESS pulmonary embolism trial. "We're thrilled to enroll the first patient and officially kick off this important clinical trial," said Dr. Shaikh. "ClotTriever is fundamentally different than other DVT treatments. This trial is designed to produce definitive evidence to change standard of care."

08:14 EST Apollo Commercial completes $3.7B of mortgage originations in 2022 - Apollo Commercial Real Estate Finance announced the Company committed to $243.1M of mortgages in the fourth quarter of 2022, bringing annual loan originations to $3.7B for the year. "ARI had a strong year of loan originations, coupled with meaningful achievements in both portfolio and capital management," said Stuart Rothstein, Chief Executive Officer and President of ARI. "The Company completed over $3.7 billion of new loan originations, many of which were funded by over $2.2 billion in loan repayments. ARI also made material progress with several of the Company's focus loans, ending the year with the sale of the properties securing our non-performing loan in the Miami Design District. In connection with the sale, we provided seller financing to the new sponsorship group, immediately redeploying a large portion of the capital. ARI continues to benefit from the strength of Apollo's global brand in the commercial real estate lending market and remains well positioned to generate distributable earnings in excess of our dividend per share of common stock in 2023." Fourth Quarter Portfolio Activity: New Investments - During the fourth quarter of 2022, ARI originated $243.1M of mortgages; Funding of Previously Closed Loans - During the fourth quarter of 2022, ARI funded $148.4M for loans closed during the preceding quarters. Loan Repayments - During the fourth quarter of 2022, ARI received $0.7B from loan repayments. Of the loan repayments, approximately 91% came from loans secured by properties in the United States and 9% came from loans secured by properties in the United Kingdom and Europe. In addition, 33% of the loan repayments were from office loans, with the balance from retail, residential, hotel, healthcare, industrial and mixed use loans.

08:13 EST Oramed down 73% after phase 3 study of ORMD-0801 did not meet primary endpoint - Shares of Oramed are down 73% or $7.92 in pre-market trading at $2.87. Last night, the company announced that the top-line results from its Phase 3 clinical trial comparing the efficacy of ORMD-0801 to placebo in patients with Type 2 Diabetes at 26 weeks did not meet its primary endpoint. The stock has also been downgraded to Hold at Canaccord this morning.

08:12 EST SAIC awarded $349M contract to support U.S. Navy tactical networks - Science Applications International has been awarded a $349M contract by the U.S. Navy to continue supporting In-Service Engineering Agent, ISEA, functions for Afloat and Ashore Tactical Networks, TACNET. "Our expertise in network engineering, modernization, sustainment and logistics positions us to provide long-term support to the U.S. Navy for afloat and ashore networks," said Bob Genter, president, Defense & Civilian Sector at SAIC. "We have provided services to this program for decades and are excited to help the Navy continue its IT modernization and transformation initiatives." Under the five-year contract, SAIC will continue to provide management, engineering, technical, integrated logistics, configuration management, and life cycle support for afloat and ashore TACNET and command, control, communications, computers, and intelligence systems.

08:11 EST True Velocity features on Field Ethos podcast with Don Trump Jr. - Texas-based ammunition manufacturer, TV Ammo, is the focus of the latest podcast hosted by Field Ethos founder and outdoorsman, Don Trump, Jr., and Field Ethos CEO Jason Vincent. The 35-minute-long interview with True Velocity Executive Vice President of Corporate Communications, Pat Hogan, focused on True Velocity's planned disruption of the global ammunition industry via the introduction of its composite-cased ammunition technology and advanced manufacturing processes that aim to revolutionize the ammunition industry. As previously announced on November 1, 2022, TV Ammo, Inc. entered into a business combination agreement with Breeze Holdings Acquisition Corp.

08:10 EST Charles River establishes eXpDNA plasmid manufacturing platform - Charles River Laboratories International announced the launch of its eXpDNA plasmid platform, established from the Company's contract development and manufacturing, CDMO, and biologics testing experience. The platform significantly reduces plasmid development and production timelines while streamlining the development journey for cell and gene therapy and vaccine developers with a focus on product quality and consistency. The platform leverages Charles River's expertise in developing, manufacturing, and releasing more than 200 High Quality and Good Manufacturing Practice-compliant plasmid DNA batches. eXpDNA supports a client's plasmid DNA strategy by offering a proven, and standardized plasmid platform approach, suitable for plasmid DNA programs across various applications.

08:09 EST Curaleaf opens Palm Beach Gardens dispensary - Curaleaf Holdings announced the opening of its Palm Beach Gardens dispensary as well as the expansion of BlueKudu infused chocolate flavors available on Florida retail menus. Located near Palm Beach Gardens at 3540 Northlake Blvd., West Palm Beach, FL 33403, the new 4,500 sq. ft. dispensary opens its doors to patients on Friday, January 13 at 9:00 a.m., with ongoing operating hours of 9:00 a.m. to 8:30 p.m. Monday through Saturday and 10:00 a.m. to 7:00 p.m. on Sunday. A grand opening celebration is planned for Friday, January 20, and will commence with a ribbon cutting at 10:00 a.m. followed by festivities throughout the day including swag giveaways, games, prizes and local vendors. Beginning on Friday, January 13, Florida patients will have access to two new flavors of BlueKudu artisanal infused chocolates: espresso dark chocolate and caramel milk chocolate. Both flavors will be available for preorder online, in-store, and via statewide delivery.

08:08 EST Pear selected by California DHCS to support recovery incentives program - The California Department of Health Care Services, DHCS, has selected Pear Therapeutics to support the implementation of the Recovery Incentives: California's Contingency Management Program. Contingency management is an evidence-based, cost-effective treatment that provides motivational incentives to treat individuals living with stimulant use disorder and support their path to recovery. The pilot program will allow eligible Medi-Cal members, across 24 counties in California, to take part in a structured 24-week outpatient program that will be followed by at least six months of additional recovery support services. Pear Therapeutics will partner with DHCS to deliver, implement, and manage this program, specifically by managing the electronic tracking and distribution of incentives to Medi-Cal members who participate in this contingency management pilot.

08:07 EST authID integrates Verified CloudConnect with Okta Workforce Identity Cloud - authID announced the integration of Verified CloudConnect with Okta's Workforce Identity Cloud and the expanded availability of Verified 3.0's full capabilities with Okta Customer Identity Cloud. authID's Human Factor Authentication can now help both Okta workforce and customer identity clients on their journey to eliminate passwords, prevent unauthorized access, as well as the business disruption caused by phishing attacks and compromised credentials.

08:06 EST Eyenovia shares evidence that Optejet delivery technology decreased inflamation - Eyenovia announced positive results from a research study conducted in collaboration with Dr. Pedram Hamrah, Interim Chairman of Ophthalmology at Tufts Medical Center, which evaluated the gene and protein expression of cytokines and chemokines after latanoprost+benzalkonium chloride treatment administered via Optejet versus latanoprost+BAK administered via standard eye drops. Preservatives are used to support product sterility and prolong shelf-life. Unfortunately, patients treated with BAK preserved glaucoma medications often suffer inflammatory side effects and develop subsequent ocular surface disease. "Chronic treatment of glaucoma with BAK preserved topical ophthalmic medications introduces ocular surface stress and may trigger a vicious cycle of inflammation," said Dr. Hamrah. "Unfortunately, the majority of glaucoma patients treated long term with drops eventually succumb to the associated inflammatory effects and discomforts of ocular surface disease."Per the in vitro study design, conjunctival epithelial cells were exposed to drug by standard drop or Optejet microdose technology. Assays were then conducted to assess inflammatory Gene expression via RT-qPCR and Protein expression by ELISA. These assays targeted the common immune biomarkers and ocular surface disease inflammatory mediators such as IL6 and MIF cytokines as well as the chemokine CCL2. The study found that the expression of Pro-Inflammatory cytokines and chemokines was decreased in two out of three cytokines with the latanoprost+BAK treatment administered via Optejet technology compared to latanoprost+BAK administered via standard drops. In these early findings, the Optejet technology appears better than latanoprost+BAK administered via standard drops in reducing inflammatory processes and pathways. Julie Whitcomb, PhD, Sr. Director of Medical Affairs at Eyenovia, commented, "The Optejet Technology shows lower levels of proinflammatory cytokines and chemokines than standard drops. The current study further underscores that precision dosing of drug and preservatives by the Optejet decreases inflammation."

08:05 EST Enphase Energy expands IQ8 microinveter deployments in Puerto Rico - Enphase Energy announced that installers of Enphase products in Puerto Rico have seen growing deployments of Enphase Energy Systems powered by IQ8 Microinverters.

08:03 EST Proterra produces first Proterra Powered EV battery at Powered 1 factory - Proterra announced that the company has produced the first Proterra Powered EV battery at its new Powered 1 battery manufacturing plant located in Greer, South Carolina. By achieving this end-to-end production milestone at Powered 1, Proterra is expected to begin deliveries to customers of Proterra Powered battery systems from the new battery factory in the first quarter of 2023. In addition, Powered 1 has started production of drivetrains and other ancillary systems incorporated into electric medium- and heavy-duty electric vehicles and equipment, such as high voltage junction boxes.

08:03 EST BigBear.ai secures 10-year multiple award $900M IDIQ contract with Air Force - BigBear.ai announced it has been awarded a multiple award $900M Indefinite Delivery/Indefinite Quantity, IDIQ, contract by the U.S. Air Force. The contract vehicle allows BigBear.ai to compete for task orders delivering capabilities, systems, and synthetic environments to the Air Force as a prime contractor. The Air Force Life Cycle Management Center, AFLCMC, Architectures and Integration Directorate expects the work on awarded task orders to be completed by 2032. Under the terms of the contract, BigBear.ai can also compete for task orders supporting the research and development of new technologies, creation of rapid prototypes, capability testing, and solution implementation. "BigBear.ai understands the importance in bringing cutting-edge and resilient solutions to each mission and we are honored to be selected for this opportunity," said Tony Barrett, President and General Manager of Federal Markets at BigBear.ai. "This contract will allow us to continue our long-term partnership with the U.S. Air Force and support as a prime contractor in future opportunities."

08:02 EST AutoZone CEO sell $12.2M in common stock - In a regulatory filing last night, AutoZone disclosed that its CEO William Rhodes sold 5K shares of common stock on January 9th in a total transaction size of $12.2M.

08:00 EST Crypto names rally as bitcoin extends gains to four-week highs - Stocks levered to bitcoin prices are trading sharply higher in pre-market hours as the cryptocurrency has extended its bounce above $18,000 overnight - its highest level in about four weeks. Bit Digital (BTBT) is up 6.3% at $1.05 per share, Riot Blockchain (RIOT) is up 4.7% at $5.62, Marathon Digital (MARA) is up 8.4% at $5.82, MicroStrategy (MSTR) is up 3.8% at $202.15 and Coinbase Global (COIN) is up 3.1% at $45.13. Silvergate Capital is also up 3.0% at $12.55.

07:50 EST Iris Energy says class action suit claims 'without merit' - The Company is aware that on December 14, 2022, a putative securities class action complaint naming the Company and certain of its directors and officers was filed in the U.S. District Court for the District of New Jersey. The filed complaint asserts claims under Section 10(b) and 20(a) of the Securities Exchange Act of 1934 and Sections 11 and 15 of the Securities Act of 1933, contending that certain of the Company's statements, including with respect to its equipment financing arrangements, were allegedly false or misleading. The Company believes these claims are without merit and intends to defend itself vigorously.

07:48 EST Iris Energy reports 123 bitcoin mined in December - Iris Energy Limited published a monthly investor update for December 2022, containing its results from operations as well as business updates. Corporate: 2.0 EH/s of total miner capacity installed, in-transit or pending deployment; Following month end, ~0.4 EH/s of S19j Pro miners was installed, increasing total Company operating capacity by greater than30% to 1.5 EH/s4; 160MW of data center capacity in BC not affected by recent BC Government decision to temporarily suspend new and early stage connection requests for cryptocurrency mining; Liquidity position and initiatives: $39 million cash, no debt; Repayment by Non-Recourse SPV 1 of all outstanding amounts under the SPV 1 Financing Agreement; Following month end, ~$6 million in net cash proceeds received from further monetization of Bitmain prepayments. Operations for the month of December 2022: Average operating hashrate of 1,086 PH/s; Monthly operating revenue of US$2.1 million; 123 Bitcoin mined. The reduction in operating metrics primarily reflects the first full month of operations following termination of hosting arrangements in connection with certain of the Group's limited recourse equipment financing facilities following receipt of an acceleration notice from the relevant lender under such facilities.

07:44 EST Nextech AR Solutions provides Q1 outlook - 2023 Q1 Outlook: Several quotes have been issued for large 3D model RFPs, which could close in Q1, 2023; The Company plans more updates for its second spin-out, of 3D Design Studio "Toggle3D" after the successful spin-out debut of ARway; ARway is rapidly moving multiple pilot projects forward which are expected to be announced shortly; Nextech Event Solutions is becoming the go-to Tech Event platform for the $50B Events industry combining: MapD, HoloX, ARitize3D and ARway into one event platform.

07:43 EST Intuitive Machines to work with Jacobs to support NASA JETS II contract - Intuitive Machines announced it will work alongside Jacobs Solutions to safely and successfully accomplish the goals and contractual requirements within NASA's Johnson Space Center Engineering, Technology, and Science, JETS, II contract. Under this agreement, Intuitive Machines is assisting Jacobs to provide engineering and scientific products, technical services, and related services for the NASA Johnson Space Center in Houston, other NASA centers, and government agencies. The total JETS II cost-plus award fee, indefinite-delivery/indefinite-quantity contract has a potential base value of approximately $1.8B. The contract contains an option to convert to a cost-plus-fixed-fee contract, and the ability to issue firm-fixed-price task orders. The contract began on Oct 1, 2022, with a five-year base period, followed by two two-year option periods and one one-year option period, which increase the potential value to approximately $3.9B. The contract has a total potential performance period of 10 years.

07:39 EST DocGo announces partnership with Redirect Health - DocGo announced a partnership with Redirect Health, a platform that creates and manages healthcare solutions for businesses and employees nationwide, to provide on-demand, urgent mobile care to patients in New Jersey and New York. The partnership will enable DocGo to provide its rapid, in-home mobile health services to thousands of Redirect Health's members across New Jersey and New York. "We couldn't be more excited to partner with Redirect Health and continue serving our patients with the best healthcare options and solutions," said Anthony Capone, CEO of DocGo. "The synergies between DocGo and Redirect Health allow us to stay true to our mission as we provide affordable and accessible care. We're looking forward to the positive impact that our partnership will bring to additional communities as we look to expand the program."

07:38 EST Marathon Gold reports additional infill drill results at Berry Deposit - Marathon provides assay results on in-fill drill holes completed at the Berry Deposit, part of the Valentine Gold Project located in central Newfoundland. During the 2022 exploration program, Marathon completed 20,931 metres of infill drilling at Berry, none of which was included in the Project's June 2022 Mineral Resource Estimate. This in-fill program targeted gaps within the existing Berry drillhole dataset that are largely assumed to be un-mineralized waste in the Berry geological model but are within the conceptual pit shells used in the MRE. Success with this program has the potential to add mineable ounces to the Project's mine plan. Assays from 9,811 metres of the 2022 drilling were previously reported. These latest results represent fire assay data from 5,490 metres of drilling in twenty-seven holes. Highlights include: VL-22-1258 intersected 5.01 g/t Au over 18 metres including 23.02 g/t Au over 1 metre and 17.90 g/t Au over 1 metre, and 4.28 g/t Au over 9 metres including 23.43 g/t Au over 1 metre, and 2.78 g/t Au over 6 metres including 11.72 g/t Au over 1 metre; VL-22-1256 intersected 3.50 g/t Au over 14 metres including 10.44 g/t Au over 1 metre. VL-22-1236 intersected 1.12 g/t Au over 46 metres. VL-22-1240 intersected 6.91 g/t Au over 7 metres including 12.86 g/t Au over 2 metres; and VL-22-1248 intersected 1.31 g/t Au over 29 metres including 16.76 g/t Au over 1 metre.

07:35 EST Medexus continues to urge medac to take steps necessary for FDA requests - The company said, "Since Medexus's last update in November 2022, medac, as the party responsible for regulatory matters under Medexus's license agreement for treosulfan, has continued to engage with the US Food and Drug Administration regarding medac's resubmission of its new drug application for treosulfan. medac's engagement has primarily focused on establishing the most appropriate approach to addressing the remaining items noted in FDA's second notice of incomplete response delivered to medac in September 2022. The FDA continues to seek supporting information from medac relating to the pivotal phase 3 clinical trial of treosulfan conducted by medac. Based on Medexus's assessment of the FDA's feedback and discussions with medac, Medexus now expects that it would take medac up to a year or more to collect and submit the information requested by the FDA. The FDA would then evaluate the completeness of the available information submitted and medac's response and, if considered to be complete, then proceed to review medac's NDA resubmission. The FDA has made clear in its communications to medac that FDA review will not progress further unless and until medac collects this supporting information and otherwise responds to the FDA's remaining requests. Medexus believes that treosulfan would make a substantial difference for US patients and therefore continues to urge medac to take the steps necessary to respond to the FDA's requests in a timely and complete fashion and fulfill medac's obligations under the terms of the treosulfan license agreement to pursue all commercially viable paths to completing the NDA resubmission. In the meantime, Medexus remains focused on commercializing the company's current product portfolio and seeking out additional complementary product opportunities that leverage the company's existing commercial platform. Medexus will continue seeking to deliver strong financial results for the company and its investors by pursuing this strategy in the near term."

07:33 EST Selina Hospitality announces the opening of its fourth hotel in Australia - Selina Hospitality announced it opened its fourth hotel in Australia, Selina Magnetic Island, on December 23rd. "We are so excited to add Selina Magnetic Island to our portfolio. It marks the 5th hotel we have opened this year in the APAC region, 4th property in Australia, and our first truly remote experience in the region," said Gadi Hassin, Managing Partner South East Asia, Australia, New Zealand Selina. "Magnetic Island is home to a beautiful local community and becoming one of Australia's most sought-after tourist destinations; we acknowledge the Wulgurukaba people of Yunbenun, the traditional custodians of the land on which we enter, and recognize their continuing connection to land, waters and community paying our respects to the Elder's past, present and future and all the Aboriginal & Torres Straight Islander people."

07:32 EST Sidus Space announces partnership with ViaSatellite - Sidus Space announced its partnership with ViaSatellite to educate industry leaders about the potential value of space-derived data in a webcast series, entitled The Future Space Economy. Carol Craig, Founder and CEO of Sidus Space, commented, "We've reached an inflection point where space-based data can be used to power predictive analytics and drive outcomes that benefit nearly every industry on Earth. Our mission is to provide access to critical space-based data so everyone can make informed decisions. We now have the knowledge and technology to get space-based data directly to end-users," continued Craig. "Understanding how these technologies and data can be used in a meaningful way has been a challenge for many. Our webinar will provide an in-depth look at the opportunities available for businesses to take advantage of this rapidly growing market. We invite industry experts and thought leaders to join us as we explore what it takes to bring Space down to Earth."

07:20 EST Applied UV secures continuing order from Fresh Taste Produce - Applied UV has secured an order for more than $400,000 for its Airocide by Sterilumen air purification systems from Fresh Taste Produce Ltd. A technology to extending the life of perishable and agriculture products is the removal of ethylene. The Airocide air purifier uses AUVI's patented Photocatalytic Oxidation technology to destroy ethylene, viruses, bacteria, spores and fungi, as well as other carbon-based microbes. "As food producers in the United States and around the world continue to face rising costs, they are looking to AUVI's patented technology to extend the shelf life and prevent spoilage of food," said Max Munn, CEO of Applied UV Inc. "We continue to see strong demand from the agricultural and food transportation sectors, as well as growers for our technology, and we anticipate both sectors to be drivers of our revenue growth in 2023."

07:16 EST Joint Corp. increases new patient count by 5% over 2021 - The Joint Corp. provided operating metrics for the year ended 2022. 2022 Full Year Operating Highlights include Performed 12.2 million patient visits, compared to 10.9 million in 2021.Treated 845,000 new patients, compared to 807,000 in 2021.Increased system-wide sales1 21%, compared to 39% in 2021.Delivered comp sales of 9%, compared to 29% in 2021.Sold 75 franchise licenses, compared to 156 in 2021. Grew total clinics to 838, 712 franchised and 126 company-owned or managed units, up from 706 clinics at December 31, 2021. Acquired 16 franchised clinics. Closed five clinics.Opened 121 franchised clinics and 16 corporate greenfield clinics, for a total of 137 new clinics in 2022, as compared to 130 new clinics in 2021. " Our team continues to excel at improving quality of life through routine and affordable chiropractic care," stated Peter D. Holt, President and Chief Executive Officer of The Joint Corp. "In 2022, we grew beyond the company records we posted in 2021. We expanded our clinic network 19%, grew the number of annual patient visits by 12% and increased our new patient count by 5% over 2021. Although lower than our historical comparisons, our 21% system-wide sales increase and 9% comp sales increase are strong in this environment. In fact, in spite of higher interest rates, inflation and consumer uncertainty, we sold 75 franchise licenses. This is a major achievement and testament to our clinic business model. In 2023, we plan to continue to broaden our national brand recognition and execute our clinic expansion strategy in a measured manner to drive long-term growth and profitability."

07:13 EST Algonquin Power hosts investor update on actions to support long-term strategy - Algonquin Power & Utilities is hosting an investor update, where President and CEO, Arun Banskota, and CFO Darren Myers, will provide an update on the actions the Company is taking to support its long-term energy transition strategy. "Over the Company's history, we have built a solid foundation supported by the scale of our asset portfolio," said Mr. Banskota. "However, we have reached an inflection point and, as markets continue to evolve, we must address the challenges facing the business. Accordingly, the board of directors and management team are taking decisive actions to strengthen our financial and strategic positions. These include taking steps to realign our capital allocation, reduce capital expenditures, refocus the portfolio, and reduce the dividend in order to position the Company for sustainable, long-term growth. We remain committed to our long-term energy transition strategy, including the pursuit of the Kentucky Power Acquisition, which we expect will add to our rate base, grow customer connections and provide further decarbonization opportunities. Our track record of operational excellence and portfolio of high-quality assets across our regulated and renewable businesses, coupled with the actions we are announcing today, are expected to enable the Company to capitalize on industry tailwinds and create meaningful value for shareholders. Moving forward, this stronger financial foundation is expected to position the Company to maintain a BBB credit rating, increase the dividend sustainably, reduce equity capital needs, and deliver solid core growth across both businesses." In connection with the investor update call, the Company highlights the following: AQN intends to further support its financial foundation, funding growth through a commitment to a BBB credit rating. AQN is focused on a balanced funding plan with no new common equity financings expected through the end of 2024 and reduced capital spending intensity. The Company currently has a strong liquidity position. Effective for its first quarter 2023 dividend, AQN intends to lower its quarterly dividend from $0.1808 to $0.1085 per common share, improving financial flexibility. AQN will continue distributions to shareholders with a sustainable dividend that is expected to grow in general alignment with Adjusted Net Earnings per share. AQN continues to pursue the Kentucky Power Acquisition. Leveraging AQN's demonstrated track record of operational excellence, the Company's pending acquisition of Kentucky Power Company and AEP Kentucky Transmission Company is expected to generate long-term value for customers and investors alike. On December 15, 2022, the U.S. Federal Energy Regulatory Commission denied approval of the Kentucky Power Acquisition as filed. The parties plan to continue to seek FERC approval of the Kentucky Power Acquisition. AQN intends to refocus its portfolio by targeting approximately $1 billion of additional asset sales. Proceeds from the next phase of renewable asset recycling and additional asset sales are expected to be used to pay down debt and continue to fund growth. AQN will be suspending its dividend reinvestment plan for its common shares. Effective for the first quarter 2023 dividend, shareholders participating in the DRIP will begin receiving cash dividends. If the Company elects to reinstate the DRIP in the future, shareholders who were enrolled in the DRIP at its suspension and remain enrolled at reinstatement will automatically resume participation in the DRIP. AQN expects Adjusted Net Earnings per common share, excluding gains or losses on asset sales, of $0.55 to $0.61 for the 2023 fiscal year.

07:10 EST Matinas BioPharma announces collaboration with National Resilience - Matinas BioPharma announced a strategic collaboration with National Resilience, "a technology-focused manufacturing company dedicated to broadening access to complex medicines." The parties have entered into a Material Transfer and Evaluation Agreement focused on exploring the potential for oral delivery of identified nucleic acids. The parties will closely collaborate on a comprehensive research program comprising the design, formulation, optimization, and in vitro and in vivo testing of these nucleic acid formats in combination with Matinas' proprietary LNC platform. Terms of the collaboration were not otherwise disclosed. "Our mission is dedicated to unlocking and delivering the full clinical potential of therapies that require intracellular delivery," said Jerome D. Jabbour, Chief Executive Officer and Co-founder of Matinas. "We are thrilled to collaborate with this world-class organization to further demonstrate the capabilities of our LNC platform. We view Resilience as an ideal platform partner and we are excited to work together with them in support of their mission to allow scientists to make their therapies quickly, safely and at scale, so patients around the world can have access to the medicines they need. Importantly, the nature of our collaboration and relationship with

07:09 EST Algonquin Power to suspend dividend reinvestment plan - AQN will be suspending its dividend reinvestment plan for its common shares. Effective for the first quarter 2023 dividend, shareholders participating in the DRIP will begin receiving cash dividends. If the Company elects to reinstate the DRIP in the future, shareholders who were enrolled in the DRIP at its suspension and remain enrolled at reinstatement will automatically resume participation in the DRIP.

07:08 EST American Airlines jumps 3.3% in premarket trading after boosting Q4 guidance

07:08 EST Algonquin Power to lower quarterly dividend to 10.85c per share - Effective for its first quarter 2023 dividend, AQN intends to lower its quarterly dividend from 18.08c to 10.85c per common share, improving financial flexibility. AQN will continue distributions to shareholders with a sustainable dividend that is expected to grow in general alignment with Adjusted Net Earnings per share

07:06 EST American Airlines achieves more than half goal to reduce total debt by $15B - The company said it has achieved more than half of its goal to reduce total debt by $15B by the end of 2025, with total debt down more than $7.5B in the first 18 months of the program.

07:06 EST Jack Creek Investment reschedules extraordinary meeting of shareholders - Jack Creek Investment announced the rescheduling of Jack Creek's extraordinary general meeting of shareholders previously scheduled to be held on January 12, 2023. The EGM has been rescheduled for January 24, 2023 at 10:00 a.m. Eastern Time. The deadline for holders of Class A ordinary shares to request that Jack Creek redeem all or a portion of their shares is, accordingly, January 20, 2023 at 5:00 p.m. Eastern Time. As previously announced, the EGM will occur at the offices of Weil, Gotshal & Manges LLP located at 767 Fifth Avenue, New York, NY 10153. The EGM is being held to vote on the proposals described in the definitive proxy statement, filed with the Securities and Exchange Commission on December 20, 2022 by Jack Creek relating to the potential business combination between Bridger Aerospace Group Holdings and Jack Creek and related transactions. The record date for the determination of shareholders entitled to vote at the EGM, including all adjournments thereof, remains November 30, 2022. The Jack Creek Board of Directors recommends that shareholders vote in favor of the proposals.

07:06 EST Virgin Orbit provides update on Start Me Up mission anomaly - The Start Me Up mission was the first orbital launch attempt in history conducted from western Europe. The flight was conducted by Virgin Orbit's air-launched LauncherOne system from the newly commissioned Spaceport Cornwall in the UK, which just a few weeks ago was transformed from a mere slab of empty cement at a commercial airport into the world's newest space launch operations center. After successfully proceeding through pre-launch operations and taking off as planned from the runway at Spaceport Cornwall, Virgin Orbit's carrier aircraft traveled to the bespoke drop zone selected for this mission and successfully released the rocket. The rocket then ignited its first stage engine, quickly going hypersonic and successfully completing the stage one burn. Initial data assessments indicate that the first stage of the rocket performed as expected, that the rocket reached space altitudes, and that stage separation, ignition of the upper stage, and fairing separation similarly occurred per the planned mission timeline. Later in the mission, at an altitude of approximately 180 km, the upper stage experienced an anomaly. This anomaly prematurely ended the first burn of the upper stage. This event ended the mission, with the rocket components and payload falling back to Earth within the approved safety corridor without ever achieving orbit. Virgin Orbit's carrier aircraft and its crew returned safely to Spaceport Cornwall. Update on the Investigation and Next Steps: Virgin Orbit has initiated a formal investigation into the source of the second stage failure. An extensive fault analysis and investigation and completion of all required corrective actions identified during the investigation will be completed prior to the next flight. Virgin Orbit is continuing to process its next scheduled rocket through final integration and checkout ahead of its upcoming mission, which is planned to occur from the Mojave Air and Space Port in California.

07:05 EST American Airlines flew 66B total ASMs, down 6.1% vs. 4Q19 - In a regulatory filing, American Airlines said it flew 66.0 billion total available seat miles in Q4, down 6.1% versus the fourth quarter of 2019, near the mid-point of its prior guidance of down 5% to 7%. Fourth quarter total revenue per available seat mile is expected to be up approximately 24% versus the fourth quarter of 2019, higher than its previous guidance of up 18% to 20%. The company expects fourth quarter CASM-ex to be up approximately 10%, compared to its previous guidance of up between 8% and 10%.

07:03 EST EVgo launches EVgo ReNew to improve charging experience nationwide - EVgo announced EVgo ReNew, a maintenance program designed to ensure stations across EVgo's charging network meet its quality and technology standards. Through the program, EVgo plans to replace, upgrade, or in some cases retire, hundreds of stations over the coming year with the goals of enhancing charger availability and building range confidence for EV drivers of all types. "More than a decade ago, EVgo was one of the first companies to install public fast chargers. The EVgo ReNew program represents our ongoing dedication to reliability as we proactively modernize legacy infrastructure and work to deliver the consistent, high-quality charging experience customers expect across our network," said Cathy Zoi, CEO at EVgo. "As more EVs come to market with expanded ranges, large battery packs and higher power charging capabilities, EVgo is invested in building and maintaining a charging network fit to welcome and support an all-electric future for every driver."

07:02 EST WisdomTree reports monthly metrics for December 2022 - WisdomTree released monthly metrics for December 2022, including assets under management, AUM, and flow data by asset class. Key Highlights: 2022 net inflows over $12 billion, nearly 16% firm-wide organic growth, with net inflows in 7 of its 8 major product categories during the year. Q4 net inflows over $5 billion. Nine consecutive quarters of net inflows with record year-end AUM of nearly $82B. U.S. Equity products have generated net inflows in 30 of the prior 31 months, including $472 million in December and $3.3 billion of net inflows for the full year - a 14% pace of organic growth in 2022. WisdomTree announced nine new blockchain-enabled funds effective with the SEC, bringing the total to ten effective digital funds. These funds are in addition to the dollar and gold tokens that the firm is making available through WisdomTree PrimeTM.

06:58 EST Logitech falls 16% to $57.06 after cutting FY23 revenue growth view - The company's Q3 revenue outlook also came in below consensus estimates.

06:49 EST Korn Ferry to realign workforce, eliminate underutilized office space - In a regulatory filing, Korn Ferry said, "In light of the company's evolution to an organization that is selling larger integrated solutions in a world where there are shifts in global trade lanes and persistent inflationary pressures, on January 11, 2023, the company initiated a plan intended to realign its workforce with its business needs and objectives, namely, to invest in areas of potential growth and implement reductions where there is excess capacity. In addition to headcount reductions (which will affect less than five percent of the company's employees), the company will further reduce its cost base by eliminating underutilized office space. The Plan is expected to be substantially completed by the end of fiscal 2023. The Plan is expected to reduce the company's annualized cost base by approximately $45.0 million to $55.0 million (after taking into account new hires in connection with the rebalancing of the company's workforce) and is expected to result in an estimated pre-tax charge of approximately $45.0 million to $50 million, consisting of severance and related employee benefit payments and lease termination costs. These charges are expected to include approximately $30.0 million to $35.0 million of cash expenditures, the majority of which will be paid during the remainder of fiscal 2023."

06:46 EST Lazard reports preliminary AUM $216.1B as of December 31, 2022 - The month's AUM included market depreciation of $5.7B, foreign exchange appreciation of $2.9B and net outflows of $2.1B. Preliminary average assets under management for the quarter ended December 31, 2022 were $211.2B.

06:31 EST University of British Columbia establishes Trimble Technology Lab - Trimble and the Faculty of Forestry at the University of British Columbiaare collaborating to establish a state-of-the-art Trimble Technology Lab at UBC's Forest Sciences Centre. Among the lab technologies that will help expand teaching and research opportunities are computer-based decision support systems, 3D modeling software, rugged field-tablets and 3D laser scanners. Educational areas that will benefit from this new lab space include silviculture, stand dynamics, forest biometrics, carbon management, sustainable harvesting systems and resource identification, quantification and many more.

06:21 EST Ormat Technologies secures financing agreement for Iien Geothermal Project - Ormat Technologies and PT Medco Power Indonesia through their subsidiary company, PT Medco Cahaya Geothermal or MCG, signed a Financing Agreement with PT Sarana Multi Infrastruktur or SMI, for the development of Ijen Geothermal Power Plant. The Ijen power plant will be developed in stages with the first phase of the development is expected to generate 34 MW in 2025. MCG, a jointly owned company between Medco Power and Ormat Technologies - 49% equity share -, will develop and operate the first geothermal power plant in East Java. Ormat also signed a contract as a key contractor on OEC supply for this project.

06:09 EST Radware launches new cloud security centers in Australia, Canada, New Zealand - Radware launched new cloud security centers in Melbourne, Australia, Toronto, Canada, and Auckland, New Zealand. The facilities will reduce traffic latency as well as increase service redundancy and mitigation capacity to help customers defend against denial-of-service attacks, web application attacks, malicious bot traffic, and attacks on APIs. It will also help them comply with offshore data routing requirements. In addition to Australia, Canada, and New Zealand, the company recently launched security centers in Chile, Italy, Taiwan, and the United Arab Emirates. The launch of the new facilities extends the company's mitigation capacity to 12Tbps across a network that is made up of more than 50 security centers worldwide.

06:06 EST Stellus Capital raises quarterly dividend 43% to 40c per share - Stellus Capital Investment Corporation announced that its Board of Directors has declared a monthly dividend of 13.33c for each of January, February, and March, totaling 40c per share in the aggregate for the first quarter of 2023. Robert Ladd, CEO, stated, "I am pleased to announce a regular dividend for the first quarter of 2023 of 40c per share, in the aggregate, payable monthly. This dividend reflects a 43% increase over the fourth quarter regular dividend of 28c per share or an 18% increase over the combined fourth quarter dividends of 34c per share which included a regular dividend of 28c per share plus an additional dividend of 6c per share. This increase in our dividend reflects the greater earnings that we are generating in this higher interest rate environment in which our loan portfolio is over 95% floating rate and our liability structure is over 65% fixed rate."

06:03 EST TSMC sees FY23 capital budget $32B-$36B

06:02 EST Coty extends license agreement with Jil Sander - Coty and Jil Sander renewed their license agreement as well as the mutual decision to proceed with a long running partnership between the two companies. The renewal of the license agreement paves the way for a new 10-year strategic project which will see Jil Sander brand stepping into global ultra-premium fragrances' segment for the first time.

05:57 EST Biophytis receives Nasdaq notice of non-compliance - Biophytis received a deficiency notice from The Nasdaq Stock Market stating that the company has not filed its financial information for the six-month period ended June 30, 2022 on a Form 6-K and as a result the company no longer complies with Nasdaq's listing rules for continued listing set forth in the Listing Rule 5250(c)(2). The company is currently working on the Plan to regain compliance with respect to the Listing Rule 5250(c)(2) to meet the requirements for continued listing on the Nasdaq Capital Market. It intends to submit such Plan to Nasdaq as soon as practicable prior to March 6.

05:49 EST NBC News President Noah Oppenheim stepping down - NBC News' longtime president, Noah Oppenheim, is stepping down but will stay with NBCUniversal to produce movies and scripted television shows, the company announced Wednesday. Oppenheim, who led NBC News for six years and oversaw the "TODAY" show for two years before that, will produce projects in partnership with NBCUniversal, Cesar Conde, the chairman of the NBCUniversal News Group, said in a statement to employees. Rebecca Blumenstein, a deputy managing editor of The New York Times since 2017, will step into the new role of president of editorial, Conde said. "We are excited for his new chapter and that he will continue to work closely with NBCUniversal in this new role," Conde said of Oppenheim. "We are grateful for his leadership and the many accomplishments of NBC News during his tenure." Reference Link